VIPR2 Antikörper (Extracellular Domain, N-Term)
Kurzübersicht für VIPR2 Antikörper (Extracellular Domain, N-Term) (ABIN2384691)
Target
Alle VIPR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Extracellular Domain, N-Term
-
Kreuzreaktivität
- Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Rt
-
Produktmerkmale
- Vasoactive intestinal Polypeptide Receptor 2 (VIP Receptor 2, VIP2R, VIPR2, Helodermin Preferring VIP Receptor, Helodermin-preferring VIP Receptor, Pituitary Adenylate Cyclase Activating Polypeptide Type III Receptor, PACAP Type III Receptor, VPAC2, VPAC2 Receptor)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- 19aa peptide from rat VIPR2. Location: ~N-terminus, Extracellular domain. No significant homology is observed with VIPR1. Species Sequence Homology: Mouse - 94%, Human - 86%.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- Supplied as a lyophilized powder from PBS, 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Andere Bezeichnung
- Vasoactive Intestinal Polypeptide Receptor 2
-
Pathways
- cAMP Metabolic Process
Target
-